» Articles » PMID: 37880830

Sex Differences in Coronary Artery Disease: Insights From the KoRean WOmen'S Chest Pain REgistry (KoROSE)

Overview
Journal Korean Circ J
Date 2023 Oct 26
PMID 37880830
Authors
Affiliations
Soon will be listed here.
Abstract

Interest in sex differences in coronary artery disease (CAD) has been steadily increasing. Concurrently, most of the data on these differences have primarily been Western-oriented. The KoRean wOmen'S chest pain rEgistry (KoROSE), started in 2011, has since published numerous research findings. This review aims to summarize the reported differences between men and women in CAD, integrating data from KoROSE. Cardiovascular risk in postmenopausal women escalates dramatically due to the decrease in estrogen levels, which normally offer cardiovascular protective effects. Lower estrogen levels can lead to abdominal obesity, insulin resistance, increased blood pressure, and endothelial dysfunction in older women. Upon analyzing patients with CAD, women are typically older and exhibit more cardiovascular risk factors than men. Diagnosing CAD in women tends to be delayed due to their symptoms being more atypical than men's. While in-hospital outcome was similar between sexes, bleeding complications after percutaneous coronary intervention occur more frequently in women. The differences in long-term prognosis for CAD patients between men and women are still a subject of ongoing debate. Pregnancy and reproductive factors also play a significant role as risk factors for cardiovascular disease in women. A notable sex disparity exists, with women found to use fewer cardiovascular protective drugs and undergo fewer interventional or surgical procedures than men. Additionally, women participate less frequently than men in clinical research. Through concerted efforts to increase awareness of sex differences and mitigate sex disparity, personalized treatment can be provided. This approach can ultimately improve patient prognosis.

Citing Articles

Sex-Based Differences and Outcomes in Unselected Patients Undergoing Coronary Angiography.

Kuhn L, Schupp T, Steinke P, Weidner K, Bertsch T, Rusnak J J Clin Med. 2025; 14(1.

PMID: 39797307 PMC: 11721804. DOI: 10.3390/jcm14010224.


Current status of modifiable risk factors for cardiovascular disease in Korean women.

Cho I, Shin M Korean J Intern Med. 2024; 40(1):15-23.

PMID: 39434602 PMC: 11725476. DOI: 10.3904/kjim.2024.077.

References
1.
Agarwala A, Goldberg A . Special Considerations for Lipid-Lowering Therapy in Women Reflecting Recent Randomized Trials. Curr Atheroscler Rep. 2021; 23(8):42. DOI: 10.1007/s11883-021-00942-3. View

2.
Marwick T, Shaw L, Case C, Vasey C, Thomas J . Clinical and economic impact of exercise electrocardiography and exercise echocardiography in clinical practice. Eur Heart J. 2003; 24(12):1153-63. DOI: 10.1016/s0195-668x(03)00113-1. View

3.
OKelly A, Michos E, Shufelt C, Vermunt J, Minissian M, Quesada O . Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women. Circ Res. 2022; 130(4):652-672. PMC: 8870397. DOI: 10.1161/CIRCRESAHA.121.319895. View

4.
Takagi K, Chieffo A, Shannon J, Naganuma T, Tahara S, Fujino Y . Impact of gender on long-term mortality in patients with unprotected left main disease: The Milan and New-Tokyo (MITO) Registry. Cardiovasc Revasc Med. 2016; 17(6):369-74. DOI: 10.1016/j.carrev.2016.05.007. View

5.
Iorga A, Cunningham C, Moazeni S, Ruffenach G, Umar S, Eghbali M . The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017; 8(1):33. PMC: 5655818. DOI: 10.1186/s13293-017-0152-8. View